Elizabeth Reed

Track

Insider profile

Currently holds positions in Travere Therapeutics Inc and Anadys Pharmaceuticals Inc

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 67% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Senior Vice President, General Counsel and Corporate Secretary Travere Therapeutics Inc Jan. 4, 2017 -
Senior Vice President - Legal Affairs and General Counsel Anadys Pharmaceuticals Inc Aug. 1, 2009 -
Vice President, General Counsel, Secretary Eiger BioPharmaceuticals Inc June 1, 2014 - March 22, 2016
Elizabeth Reed's trades of Travere Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
65.79
Quantity 39,576
Value US$2,603,705
Transaction date
Proposed sale
Price
43.95
Quantity 2,076
Value US$91,240
Transaction date
Proposed sale
Price
45.00
Quantity 20,000
Value US$900,000
Transaction date
Proposed sale
Price
41.83
Quantity 6,785
Value US$283,823
Transaction date
Proposed sale
Price
41.07
Quantity 37,500
Value US$1,540,125
Transaction date
Proposed sale
Price
30.00
Quantity 10,000
Value US$300,000
Transaction date
Proposed sale
Price
28.09
Quantity 10,000
Value US$280,861
Transaction date
Proposed sale
Price
27.83
Quantity 10,000
Value US$278,317
Transaction date
Proposed sale
Price
32.18
Quantity 2,994
Value US$96,360
Transaction date
Proposed sale
Price
27.34
Quantity 10,000
Value US$273,420
Transaction date
Proposed sale
Price
25.00
Quantity 10,000
Value US$250,000
Transaction date
Proposed sale
Price
21.05
Quantity 4,920
Value US$103,566
Transaction date
Proposed sale
Price
23.53
Quantity 8,000
Value US$188,240
Transaction date
Proposed sale
Price
19.78
Quantity 8,951
Value US$177,051
Transaction date
Proposed sale
Price
19.46
Quantity 2,437
Value US$47,424
Transaction date
Proposed sale
Price
11.52
Quantity 4,387
Value US$50,538
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-17 2026-09-15
PlS Planned sale
20,249 +5.9%
168.33
US$1,799,961 		20,249 +5.9% 168.33 US$1,799,961
2026-09-17 2026-09-15
PlS Planned sale
28,189 -37.0%
229.75
US$2,927,838 		28,189 -37.0% 229.75 US$2,927,838
2026-09-17 2026-09-15
PlS Planned sale
18,226 +41.1%
405.44
US$4,879,683 		18,226 +41.1% 405.44 US$4,879,683
2026-09-17 2026-09-15
PlS Planned sale
21,926 -15.3%
62.03
US$1,359,971 		21,926 -15.3% 62.03 US$1,359,971
2026-09-15 2026-09-15
PrS Proposed sale
39,576
65.79
US$2,603,705 		39,576 65.79 US$2,603,705
2026-05-06 2026-05-06
PlS Planned sale
2,076 -1.9%
43.95
US$91,240 		2,076 -1.9% 43.95 US$91,240
2026-05-06 2026-05-06
PrS Proposed sale
2,076
43.95
US$91,240 		2,076 43.95 US$91,240
2026-05-06 2026-05-05
S Sale
2,174 -2.0%
46.65
US$101,417 		2,174 -2.0% 46.65 US$101,417
2026-05-05 2026-05-05
PrS Proposed sale
2,174
46.65
US$101,417 		2,174 46.65 US$101,417
2026-05-06 2026-05-04
PlS Planned sale
20,000 -16.0%
45.00
US$900,000 		20,000 -16.0% 45.00 US$900,000
2026-05-04 2026-05-04
PrS Proposed sale
20,000
45.00
US$900,000 		20,000 45.00 US$900,000
2026-04-15 2026-04-15
PlS Planned sale
1,559 -1.5%
42.53
US$66,304 		1,559 -1.5% 42.53 US$66,304
2026-04-15 2026-04-15
PlS Planned sale
5,226 -4.7%
41.62
US$217,506 		5,226 -4.7% 41.62 US$217,506
2026-04-15 2026-04-15
PrS Proposed sale
6,785
41.83
US$283,823 		6,785 41.83 US$283,823
2026-04-15 2026-04-14
S Sale
7,215 -6.1%
41.93
US$302,516 		7,215 -6.1% 41.93 US$302,516
2026-04-15 2026-04-14
PlS Planned sale
37,500 -23.9%
41.07
US$1,540,125 		37,500 -23.9% 41.07 US$1,540,125
2026-04-14 2026-04-14
PrS Proposed sale
7,215
41.93
US$302,516 		7,215 41.93 US$302,516
2026-04-14 2026-04-14
PrS Proposed sale
37,500
41.07
US$1,540,125 		37,500 41.07 US$1,540,125
2026-04-02 2026-04-01
PlS Planned sale
10,000 -8.7%
30.00
US$300,000 		10,000 -8.7% 30.00 US$300,000
2026-04-02 2026-04-01
PlS Planned sale
10,000 -8.7%
30.00
US$300,000 		10,000 -8.7% 30.00 US$300,000
2026-04-01 2026-04-01
PrS Proposed sale
10,000
30.00
US$300,000 		10,000 30.00 US$300,000
2026-03-18 2026-03-16
PlS Planned sale
10,000 -8.7%
28.09
US$280,861 		10,000 -8.7% 28.09 US$280,861
2026-03-16 2026-03-16
PrS Proposed sale
10,000
28.09
US$280,861 		10,000 28.09 US$280,861
2026-02-19 2026-02-17
PlS Planned sale
4,321 -3.9%
28.26
US$122,120 		4,321 -3.9% 28.26 US$122,120
2026-02-19 2026-02-17
PlS Planned sale
5,679 -4.9%
27.50
US$156,195 		5,679 -4.9% 27.50 US$156,195
2026-02-17 2026-02-17
PrS Proposed sale
10,000
27.83
US$278,317 		10,000 27.83 US$278,317
2026-02-05 2026-02-04
PlS Planned sale
509 -0.5%
32.74
US$16,665 		509 -0.5% 32.74 US$16,665
2026-02-05 2026-02-04
PlS Planned sale
2,485 -2.3%
32.07
US$79,694 		2,485 -2.3% 32.07 US$79,694
2026-02-04 2026-02-04
PrS Proposed sale
2,994
32.18
US$96,360 		2,994 32.18 US$96,360
2026-02-03 2026-02-03
S Sale
7,175 -6.2%
32.12
US$230,461 		7,175 -6.2% 32.12 US$230,461
2026-02-03 2026-02-03
PrS Proposed sale
7,175
32.12
US$230,464 		7,175 32.12 US$230,464
2026-02-03 2026-02-03
S Sale
7,175 -6.2%
32.12
US$230,461 		7,175 -6.2% 32.12 US$230,461
2026-01-21 2026-01-20
PlS Planned sale
10,000 -10.0%
27.34
US$273,420 		10,000 -10.0% 27.34 US$273,420
2026-01-20 2026-01-20
PrS Proposed sale
10,000
27.34
US$273,420 		10,000 27.34 US$273,420
2025-09-24 2025-09-22
PlS Planned sale
10,000 -10.0%
25.00
US$250,000 		10,000 -10.0% 25.00 US$250,000
2025-09-22 2025-09-22
PrS Proposed sale
10,000
25.00
US$250,000 		10,000 25.00 US$250,000
2025-05-05 2025-05-05
PrS Proposed sale
4,920
21.05
US$103,566 		4,920 21.05 US$103,566
2025-05-05 2025-05-05
PlS Planned sale
4,920 -5.2%
21.05
US$103,566 		4,920 -5.2% 21.05 US$103,566
2025-02-12 2025-02-12
PrS Proposed sale
8,000
23.53
US$188,240 		8,000 23.53 US$188,240
2025-02-12 2025-02-12
PlS Planned sale
8,000 -8.2%
23.53
US$188,240 		8,000 -8.2% 23.53 US$188,240
2025-02-04 2025-02-03
PlS Planned sale
8,951 -9.1%
19.78
US$177,051 		8,951 -9.1% 19.78 US$177,051
2025-02-03 2025-02-03
PrS Proposed sale
8,951
19.78
US$177,051 		8,951 19.78 US$177,051
2025-01-23 2025-01-22
PlS Planned sale
2,437 -3.1%
19.46
US$47,424 		2,437 -3.1% 19.46 US$47,424
2025-01-22 2025-01-22
PrS Proposed sale
2,437
19.46
US$47,424 		2,437 19.46 US$47,424
2024-09-09 2024-09-09
PrS Proposed sale
4,387
11.52
US$50,538 		4,387 11.52 US$50,538